Results 241 to 250 of about 93,801 (340)
Why, When, and How to Treat Dynamic Forehead Lines with Botulinum Toxin Type A. [PDF]
de Sanctis Pecora C +3 more
europepmc +1 more source
Innovative Drug Delivery Systems for the Treatment of Glaucoma
This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu +9 more
wiley +1 more source
Dynamic Evaluation of Glabellar Area Muscles Movement and Skin Displacement Using 3D Skin Displacement Vector Analysis. [PDF]
Moon HJ, Cho JM, Lee SE.
europepmc +1 more source
ABSTRACT Exchanges in franchise systems are embedded in the level of trust that exists in franchisee–franchisor relationships. Although trust is essential in business relationships, it can unfold a negative side effect on the appreciation of exchange in these relationships as hidden costs of trust.
Matthias Glaser +2 more
wiley +1 more source
Treatment and Prevention of Traumatic Eyebrow Cicatricial Alopecia With Stem Cell Growth Serum. [PDF]
Ong KHX, Lee SJ.
europepmc +1 more source
Interpretation Of Forehead and Eyebrow Movements in Different System Languages
Tursunova Farangiz Dildorbekovna
openalex +2 more sources
Cooling down for going up: Could selective ‘brain chilling’ mitigate high‐altitude illness?
Experimental Physiology, EarlyView.
Adnan Haq, Damian M. Bailey
wiley +1 more source
ABSTRACT Introduction/Aims Facioscapulohumeral muscular dystrophy (FSHD) is a muscle disease that leads, among other manifestations, to facial weakness. This weakness can severely impact communication and quality of life, yet it remains under‐researched with limited objective clinical measures.
T. G. J. Loonen +9 more
wiley +1 more source
Alezzandrini syndrome mimicking shingles - A rare case report with review of literature.
Singh M +5 more
europepmc +1 more source

